Proposal of Latin-American guidelines for smoking cessation;Guías de atención médica para dejar de fumar. Una propuesta para Latinoamérica

Salud Publica de Mexico

Volumn 52, Issue SUPPL.2, 2010, Pages

  Sansores, Raúl H ^a   Pérez Bautista, Oliver ^a   Ramírez Venegas, Alejandra ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

Guidelines for smoking cessation; Tobacco smoking

Indexed keywords

EID: 78651228487     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: 10.1590/s0036-36342010000800034     Document Type: Article

References (44)

1. Pérez-Bautista O, Ramírez-Venegas A, Escobar-Arriaga E, Sansores RH. Differences in inflammatory markers in a non-smoking and smoking Mexican population. Rev Invest Clin 2009;61:205-11.
2. Ezzati M, López AD. Estimates of global mortality attributable to smoking in 2000. Lancet 2003;362:847-52.
3. Ezzati M, Henley SJ, Thun MJ, López AD. Role of smoking in global and regional cardiovascular mortality. Circulation. 2005;112:489-97.
4. Menezes AM, Lopez MV, Hallal PC, Muiño A, Pérez-Padilla R, Jardim JR, et al and the PLATINO Team. Prevalence of smoking and incidence of initiation in the Latin American adult population: the PLATINO study. BMC Public Health 2009;9:151.
5. Sansores RH, Ramírez-Venegas. Guías Mexicanas para el tratamiento del tabaquismo. Un consenso nacional de expertos. Neumología y Cirugía de Tórax 2005;64(S2):S84-S109.
6. Müller F, Webe L. Smoking and smoking cessation in Latin America: a review of the current situation and available treatments. Int J Chron Obstruct Pulmon Dis 2008;3(2):285-293.
7. Slama, K. Prevención y control del tabaquismo. Guía para países con escasos recursos económicos. International Union Against Tuberculosis and Lung Disease Paris, 2000.
8. Reichert J, Araújo A, Cantarino Goncalvez CM, Godoy I, Chatkin JM, Uchoa M, et al. Smoking Cessation Guidelines 2008 J Bras Pneumol 2008;34(10):845-880.
9. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Updated 2009. [consultado 2010 enero 18] Disponible en: http://www.goldcopd.com/Guidelineitem.asp?l1=2&l2=1&intId=2003.
10. Raw M, Regan S, Rigotti N, Mc Neill A. A survey of tobacco dependence treatment services in 36 countries. Adicction 2009;104(2):279-287.
11. Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Treating tobacco use and dependence: 2008 update US Public Health Service Clinical Practice Guideline executive summary. Respir Care 2008;53(9)1217-1222.
12. Moore D, Aveyard P, Connock M, Wang D, Fry-Smith A, Barton P. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: Systematic review and meta-analysis. BMJ 2009;338:b1024.
13. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2007;1:CD000031.
14. Eisenberg MJ, Filion KB, Yavin D, Bélisle P, Motillo S, Joseph L, et al. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. CMAJ 2008;179(2):135-44.
15. Wu P, Wilson K, Dimoulas P, Mills EJ. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health 2006;6:300.
16. Demyttenaere K, Jaspers L. Bupropion and SSRI-induced side effects. J Psychopharmacology 2008;22:792-804.
17. Nides M. Update on Pharmacologic Options for Smokings Cessation Treatment. Am J Med 2008;121(4):S20-S31.
18. Boshier A, Wilton LV, Shakir SA. Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000. Eur J Clin Pharm 2003;59:767-73.
19. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial Agonists for smoking cessation. Cochrane Database Syst Rev 2007;16(1):CD006103.
20. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial Agonists for smoking cessation. Cochrane Database Syst Rev 2008;16(3):CD006103.
21. Garrison GD, Dugan SE. Varenicline: a first-line treatment option for smoking cessation. Clin Ther 2009;31(3):463-491.
22. Annemans L, Nackaerts K, Bartsch P, Prignot J, Marbaix S. Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis. Clin Drug Investig 2009;29:655-65.
23. Hind D, Tappenden P, Peters J, Kenjegalieva K. Varenicline in the management of smoking cessation: a single technology appraisal. Health Technol Assess 2009;13(S2):9-13.
24. Shah SD, Wilken LA, Winkler SR, Lin SJ. Systematic review and meta-analysis of combination therapy for smoking cessation. J Am Pharm Assoc 2008;48:659-665.
25. Covino NA, Bottari M. Hypnosis, behavioral theory, and smoking cessation. J Dent Educ 2001;65(4):340-7.
26. Barron J, Petrilli F, Strath L, McCaffrey R. Successful interventions for smoking cessation in pregnancy. Am J Matern Child Nurs 2007;32(1):48-49.
27. Grimshaw GM, Stanton A. Tobacco cessation interventions for young people. Cochrane Database Syst Rev 2006;(4):CD003289.
28. Shahab L, McEwen A. Online support for smoking cessation: a systematic review of the literature. Addiction 2009;104:1792-1804.
29. Cabioglu MT, Ergene N, Tan U. Smoking cessation after acupuncture treatment. Int J Neurosci 2007;117(5):571-578.
30. Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev 2005;(2):CD001007.
31. Méndez Guerra M, Urdapilleta E, Sansores RH, Lara Rivas G, Ramírez-Venegas A, Regalado-Pineda J, et al. Factores que determinan que un paciente ingrese a un programa para dejar de fumar. Rev Inst Nal Enf Resp Mex 2009;22(1):7-13.
32. Flores-Trujillo F, Ramírez-Venegas A, Hernández-Zenteno R, Méndez Guerra M, Sansores RH. Comparación del éxito para dejar de fumar a largo plazo en sujetos con EPOC y sin EPOC. Rev Inst Nal Enf Resp Mex 2009;22(1):21-28.
33. Gordon L, Graves N, Hawkes A, Eakin E. A review of the cost-effectiveness of face-to-face behavioural interventions for smoking, physical activity, diet and alcohol. Chronic Illn 2007;3(2):101-129.
34. Bodner ME, Dean E. Advice as a smoking cessation strategy: a systematic review and implications for physical therapists. Physiother Theory Pract 2009;25:369-407.
35. Stead LF, Bergson G, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev 2008;(2):CD000165.
36. Rice VH, Stead LF. Nursing interventions for smoking cessation. Cochrane Database Syst Rev 2008;(1):CD001188.
37. Stead LF, Lancaster T. Interventions to reduce harm from continued tobacco use. Cochrane Database Syst Rev 2007;(3):CD005231.
38. Hays JT, Ebber JO, Sood A. Treating Tobacco Dependence in Light of the 2008 US Department of Health and Human Services Clinical Practice Guideline. Mayo Clin Proc 2009;84(8):730-736.
39. Reus VI, Smith BJ. Multimodal techniques for smoking cessation: a review of their efficacy and utilization and clinical practice guidelines. Int J Clin Pract 2008;62(11):1753-1768.
40. Reynales-Shigematsu LM. Costos de atención médica de las enfermedades atribuibles al consumo de tabaco en América: revisión de la literatura. Salud Publica Mex 2006;48(suppl 1):S190-S200.
41. Instituto Nacional de Estadística, Geografía e Informática. Encuesta Nacional de la Dinámica Demográfica 2006 (ENADID 2006). México: INEGI, 2006.
42. Kuri-Morales PA, González-Roldán JF, Hoy MJ, Cortés-Ramírez M. Epidemiología del tabaquismo en México. Salud Publica Mex 2006;48(supl 1):S91-S98.
43. Rubio H, Sansores RH, Oviedo MT, Espinosa M, Vélez BA, Castrejón V. Modelo para la prestación de servicios en materia de tabaquismo en México. Rev Ins Nal Enf Resp Mex 2003;16:92-102.
44. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008;(1):CD000146.